Skip to main content
. 2016 Jul 8;11(7):e0158639. doi: 10.1371/journal.pone.0158639

Fig 4. Histology of ahMNCs and hTERT-ahMNCs in vivo tumorigenicity.

Fig 4

ahMNCs and hTERT-ahMNCs were injected into neonate NOG mice via the intracranial (IC) route. A hematoxylin and eosin (H&E) stained histological analysis showed no tumor formation in the ahMNCs and hTERT-ahMNCs-injected groups 6 months after injection. However, the U87MG injected groups developed brain tumors.